Coronaviruses
Volume 1, 4 Issues, 2020
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access
The first issue will be published as Open Access (free to view) for 3 months only.
Order Your Article Before PrintSubscribe to this Journal
The publication process of all articles will be expedited, for timely publication of much needed research
Aims & Scope
Coronaviruses publishes original research articles, letters, reviews/mini-reviews, clinical trial and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc.
The Journal also covers case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment and development of new therapeutics.
Coronaviruses
,Volume 1
-Number 1
Preface Free Content
Preface
Foreword Free Content
Foreword
Foreword Free Content
Foreword
Letter to the Editor Free Content
A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
, 1(1): 4 - 6Alex Y. Strongin, Alex Sloutsky and Piotr Cieplak*
DOI: 10.2174/2666796701999200629003417
A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
Letter to the Editor Free Content
The COVID-19 and Ageism in Social Media
, 1(1): 7 - 8Yadollah Abolfathi Momtaz*
DOI: 10.2174/2666796701999200621203144
The COVID-19 and Ageism in Social Media
Perspective Free Content
nCovid-19 in 2020: From Despair to Hope
, 1(1): 9 - 12Ravi Varala* and Haribabu Bollikolla
DOI: 10.2174/2666796701999200621202839
nCovid-19 in 2020: From Despair to Hope
Research Article Free Content
Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach
, 1(1): 13 - 22Rajagopal Kalirajan*
DOI: 10.2174/2666796701999200625210746
Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach
Review Article Free Content
Potential Immunotherapy against SARS-CoV-2: Strategy and Status
, 1(1): 23 - 31Abid H. Banday*, Shameem A. Shah and Sheikh J. Ajaz
DOI: 10.2174/2666796701999200625212040
Potential Immunotherapy against SARS-CoV-2: Strategy and Status
Articles Ahead of Print
Review of the Times When One-Third of the Mankind is Under Lockdown due to Coronavirus
Pramod Gware* and Deepanshu Gulati
DOI: 10.2174/2666796701999201026211733
View Abstract
A Mini-review on Cardiovascular and Hematological Complications of COVID-19
Moein Masjedi* and Pegah Jafari
DOI: 10.2174/2666796701999201026211142
View Abstract
Vaccine development against SARS-CoV-2: from virology to vaccine clinical trials
Kimia Kardani* and Azam Bolhassani
DOI: 10.2174/2666796701999201026205553
View Abstract
Manuscript title: “COVID-19 pandemic: care for Indian cancer patients”
Sandeep Kumar*
DOI: 10.2174/2666796701999201026205030
View Abstract
The Current Outbreak of COVID-19 with reference to India
Harshita Gupta*
DOI: 10.2174/2666796701999201026203911
View Abstract
Nanomaterial: A Sustainable Way to Fight against COVID-19
Atish K. Maldhure*
DOI: 10.2174/2666796701999201022192504
View Abstract
Impact of Online Teaching on Students’ Education and Health in India during the Pandemic of COVID-19
Avadhesh Kumar Yadav*
DOI: 10.2174/2666796701999201005212801
View Abstract
Understanding the Role of HDL during COVID-19 Infection
Iti Garg*, Swati Srivastava and Bhuvnesh Kumar
DOI: 10.2174/2666796701999200918160757
View Abstract
Compressive review on epidemiology, diagnosis and auspicious management on COVID 19
Pratibha Auti*, Sagar Kothawade, Anagha Soundankar and Vinayak Kumbhar
DOI: 10.2174/2666796701999201021150744
View Abstract
COVID-19 Epigenetics and Implications for Public Health
Verda Tunalıgil, Gülsen Meral, Ahmet Katı*, Dhrubajyoti Chattopadhyay and Amit Kumar Mandal*
DOI: 10.2174/2666796701999201005212515
View Abstract
Abstracts Ahead of Print
There are currently no Abstracts Ahead of Print available for this journal.
Published Contents
Editor's Choice
Potential Drug Options for Treatment of COVID-19: A Review
, 2020; 1(1): 42 - 48Tinsae Kebede, Dharmendra Kumar* and Pramod Kumar Sharma
DOI: 10.2174/2666796701999200701131604
Open Access Articles
Most Cited Articles
Most Accessed Articles
A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
, 2020; 1(1): 4-6.Alex Y. Strongin, Alex Sloutsky and Piotr Cieplak*
DOI: 10.2174/2666796701999200629003417
The COVID-19 and Ageism in Social Media
, 2020; 1(1): 7-8.Yadollah Abolfathi Momtaz*
DOI: 10.2174/2666796701999200621203144
COVID-19: Morphology, Characteristics, Symptoms, Prevention, Clinical Diagnosis and Current Scenario
, 2020; 1(1): 82-89.Tansukh Barupal, Praveen Kumar Tak and Mukesh Meena*
DOI: 10.2174/2666796701999200617161348
Potential Immunotherapy against SARS-CoV-2: Strategy and Status
, 2020; 1(1): 23-31.Abid H. Banday*, Shameem A. Shah and Sheikh J. Ajaz
DOI: 10.2174/2666796701999200625212040
A Preliminary Review on Novel Coronavirus Disease: COVID-19
, 2020; 1(1): 90-97.Miranji Katta*, Satish Rapaka, Ramkumar Adireddi and Jagadeeshwara Rao Emandi
DOI: 10.2174/2666796701999200615155630
nCovid-19 in 2020: From Despair to Hope
, 2020; 1(1): 9-12.Ravi Varala* and Haribabu Bollikolla
DOI: 10.2174/2666796701999200621202839
Potential Drug Options for Treatment of COVID-19: A Review
, 2020; 1(1): 42-48.Tinsae Kebede, Dharmendra Kumar* and Pramod Kumar Sharma
DOI: 10.2174/2666796701999200701131604
Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach
, 2020; 1(1): 13-22.Rajagopal Kalirajan*
DOI: 10.2174/2666796701999200625210746
Editor-in-Chief
Jean-Marc Sabatier
Institute of NeuroPhysiopathology
Marseille, Cedex
(France)
Biography
Institute of NeuroPhysiopathology
Marseille, Cedex
Biography
Biography of Jean-Marc Sabatier
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.
Nobel Laureate on Editorial Board
Prof. Ferid Murad
(USA)
About the Journal
For Authors
For Librarians & Readers
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net